Clinical Infectious Diseases and Therapeutics

Welcome to the Laboratory of Clinical Infectious Diseases!

Infectious diseases have been largely controlled through advances in antimicrobial agents and vaccines. However, in recent years, the threat has re-emerged and intensified due to the spread of antimicrobial-resistant organisms and the emergence and re-emergence of infectious diseases. Under these circumstances, it is essential to maximize the use of limited therapeutic options and provide optimal treatment tailored to individual patients.

Our laboratory focuses on optimizing infectious disease treatment and infection control from a pharmaceutical perspective. Based on the appropriate use of antimicrobial agents, therapeutic drug monitoring (TDM), and the analysis of clinical data, we aim to generate evidence that directly informs clinical practice. We also emphasize research on dosing strategies grounded in pharmacokinetics and pharmacodynamics (PK/PD), as well as studies that contribute to the implementation of effective infection control measures.

Through these efforts, we strive to advance evidence-based infectious disease therapy and to cultivate pharmacists and researchers who can bridge the gap between clinical practice and research.